{"count": 43, "results": [{"_id": "33638931", "pmid": 33638931, "title": "Effects of simvastatin on tissue factor pathway of blood coagulation in STATCOPE (Simvastatin in the prevention of COPD exacerbations) trial.", "journal": "J Thromb Haemost", "authors": ["Rao AK", "Del Carpio-Cano F", "Janapati S", "Zhao H", "Voelker H", "Lu X", "Criner G", "NIH COPD Clinical Research Network, the Canadian Institute of Health Research Investigators"], "date": "2021-07-01T00:00:00Z", "doi": "10.1111/jth.15282", "meta_date_publication": "2021 Jul", "meta_volume": "19", "meta_issue": "7", "meta_pages": "1709-1717", "score": 50267.11, "text_hl": "Effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @GENE_F3 @GENE_2152 @@@tissue factor@@@ pathway of @DISEASE_Blood_Coagulation_Disorders @DISEASE_MESH:D001778 @@@blood coagulation@@@ in STATCOPE (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in the prevention of @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ exacerbations) trial.", "citations": {"NLM": "Rao AK, Del Carpio-Cano F, Janapati S, Zhao H, Voelker H, Lu X, Criner G, NIH COPD Clinical Research Network, the Canadian Institute of Health Research Investigators. Effects of simvastatin on tissue factor pathway of blood coagulation in STATCOPE (Simvastatin in the prevention of COPD exacerbations) trial. J Thromb Haemost. 2021 Jul;19(7):1709-1717. PMID: 33638931", "BibTeX": "@article{33638931, title={Effects of simvastatin on tissue factor pathway of blood coagulation in STATCOPE (Simvastatin in the prevention of COPD exacerbations) trial.}, author={Rao AK and Del Carpio-Cano F and Janapati S and Zhao H and Voelker H and Lu X and Criner G and NIH COPD Clinical Research Network, the Canadian Institute of Health Research Investigators}, journal={J Thromb Haemost}, volume={19}, number={7}, pages={1709-1717}}"}}, {"_id": "33574076", "pmid": 33574076, "title": "Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study.", "journal": "Eur Respir J", "authors": ["Schenk P", "Spiel AO", "Hüttinger F", "Gmeiner M", "Fugger J", "Pichler M", "Pichler G", "Schmeikal S", "Janistyn W", "Schügerl S", "Sajdik C", "Herkner H"], "date": "2021-07-29T00:00:00Z", "doi": "10.1183/13993003.01798-2020", "meta_date_publication": "2021 Jul", "meta_volume": "58", "meta_issue": "1", "meta_pages": "", "score": 50266.316, "text_hl": "Can @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduce @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ exacerbations? ", "citations": {"NLM": "Schenk P, Spiel AO, Hüttinger F, Gmeiner M, Fugger J, Pichler M, Pichler G, Schmeikal S, Janistyn W, Schügerl S, Sajdik C, Herkner H. Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study. Eur Respir J. 2021 Jul;58(1):. PMID: 33574076", "BibTeX": "@article{33574076, title={Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study.}, author={Schenk P and Spiel AO and Hüttinger F and Gmeiner M and Fugger J and Pichler M and Pichler G and Schmeikal S and Janistyn W and Schügerl S and Sajdik C and Herkner H}, journal={Eur Respir J}, volume={58}, number={1}}"}}, {"_id": "34523310", "pmid": 34523310, "title": "Simvastatin represses inflammation and cell apoptosis in COPD rats via rho/rho kinase signaling pathway.", "journal": "Minerva Surg", "authors": ["Zhao N", "Yu M", "Lan B", "Liang B", "Zhang Y", "DU K", "Leng B"], "date": "2021-09-15T00:00:00Z", "doi": "10.23736/S2724-5691.21.09071-7", "meta_date_publication": "2021 Sep 15", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.055, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ represses @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and cell apoptosis in @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ @SPECIES_10116 @@@rats@@@ via rho/rho kinase signaling pathway.", "citations": {"NLM": "Zhao N, Yu M, Lan B, Liang B, Zhang Y, DU K, Leng B. Simvastatin represses inflammation and cell apoptosis in COPD rats via rho/rho kinase signaling pathway. Minerva Surg. 2021 Sep 15;():. PMID: 34523310", "BibTeX": "@article{34523310, title={Simvastatin represses inflammation and cell apoptosis in COPD rats via rho/rho kinase signaling pathway.}, author={Zhao N and Yu M and Lan B and Liang B and Zhang Y and DU K and Leng B}, journal={Minerva Surg}}"}}, {"_id": "32173640", "pmid": 32173640, "title": "Clinical effect of simvastatin combined with exercise training in the treatment of stationary chronic obstructive pulmonary disease complicated with metabolic syndrome.", "journal": "Pak J Pharm Sci", "authors": ["Liu J", "Jiang N", "Liu T", "Luo W"], "date": "2020-01-01T00:00:00Z", "meta_date_publication": "2020 Jan", "meta_volume": "33", "meta_issue": "1(Special)", "meta_pages": "437-440", "score": 50254.457, "text_hl": "Clinical effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ combined with exercise training in the treatment of stationary @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive pulmonary disease@@@ complicated with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@.", "citations": {"NLM": "Liu J, Jiang N, Liu T, Luo W. Clinical effect of simvastatin combined with exercise training in the treatment of stationary chronic obstructive pulmonary disease complicated with metabolic syndrome. Pak J Pharm Sci. 2020 Jan;33(1(Special)):437-440. PMID: 32173640", "BibTeX": "@article{32173640, title={Clinical effect of simvastatin combined with exercise training in the treatment of stationary chronic obstructive pulmonary disease complicated with metabolic syndrome.}, author={Liu J and Jiang N and Liu T and Luo W}, journal={Pak J Pharm Sci}, volume={33}, number={1(Special)}, pages={437-440}}"}}, {"_id": "39937085", "pmid": 39937085, "title": "Statin treatment reduces protein carbonylation in patients with COPD: A randomized controlled study.", "journal": "Eur J Clin Invest", "authors": ["Kruk A", "Ząbczyk M", "Natorska J", "Undas A"], "date": "2025-02-12T00:00:00Z", "doi": "10.1111/eci.70009", "meta_date_publication": "2025 Feb 12", "meta_volume": "", "meta_issue": "", "meta_pages": "e70009", "score": 50252.977, "text_hl": "We investigated prothrombotic effects of increased PC content and its modulation by statin use in @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@. MATERIALS AND METHODS: We studied 56 @SPECIES_9606 @@@patients@@@ with stable @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@, who were randomly assigned in an open-label manner to receive @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg/day (n = 28) or to remain without statin for 3 months (n = 28). ", "citations": {"NLM": "Kruk A, Ząbczyk M, Natorska J, Undas A. Statin treatment reduces protein carbonylation in patients with COPD: A randomized controlled study. Eur J Clin Invest. 2025 Feb 12;():e70009. PMID: 39937085", "BibTeX": "@article{39937085, title={Statin treatment reduces protein carbonylation in patients with COPD: A randomized controlled study.}, author={Kruk A and Ząbczyk M and Natorska J and Undas A}, journal={Eur J Clin Invest}, pages={e70009}}"}}, {"_id": "35397199", "pmid": 35397199, "title": "Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life.", "journal": "Chronic Obstr Pulm Dis", "authors": ["Camac ER", "Stumpf NA", "Voelker HK", "Criner GJ"], "date": "2022-07-29T00:00:00Z", "doi": "10.15326/jcopdf.2021.0280", "meta_date_publication": "2022 Jul 29", "meta_volume": "9", "meta_issue": "3", "meta_pages": "298-308", "score": 50249.75, "text_hl": "Background: @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Chronic obstructive pulmonary disease@@@ (@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@) @SPECIES_9606 @@@patients@@@ in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ for the Prevention of Exacerbations in Moderate-to-Severe @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ (STATCOPE) and @CHEMICAL_Azithromycin @CHEMICAL_MESH:D017963 @@@Azithromycin@@@ for Prevention of Exacerbations of @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ (MACRO) trials provide an opportunity to prospectively study the short-term effect of @DISEASE_Acute_Disease @DISEASE_MESH:D000208 @@@acute exacerbations of@@@ @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ (AECOPDs). ", "citations": {"NLM": "Camac ER, Stumpf NA, Voelker HK, Criner GJ. Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life. Chronic Obstr Pulm Dis. 2022 Jul 29;9(3):298-308. PMID: 35397199", "BibTeX": "@article{35397199, title={Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life.}, author={Camac ER and Stumpf NA and Voelker HK and Criner GJ}, journal={Chronic Obstr Pulm Dis}, volume={9}, number={3}, pages={298-308}}"}}, {"_id": "34229290", "pmid": 34229290, "title": "Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.", "journal": "Respir Med", "authors": ["Camac ER", "Voelker H", "Criner GJ", "COPD Clinical Research Network and the Canadian Institutes of Health Research"], "date": "2021-09-01T00:00:00Z", "doi": "10.1016/j.rmed.2021.106526", "meta_date_publication": "2021 Sep", "meta_volume": "186", "meta_issue": "", "meta_pages": "106526", "score": 50248.56, "text_hl": "METHODS: 1219 @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ @SPECIES_9606 @@@patients@@@ enrolled in either the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for the prevention of exacerbations in moderate-to severe @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ Trial (STATCOPE) or @CHEMICAL_Azithromycin @CHEMICAL_MESH:D017963 @@@azithromycin@@@ for prevention of exacerbations of @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ trial (MACRO) were analyzed. ", "citations": {"NLM": "Camac ER, Voelker H, Criner GJ, COPD Clinical Research Network and the Canadian Institutes of Health Research. Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life. Respir Med. 2021 Sep;186():106526. PMID: 34229290", "BibTeX": "@article{34229290, title={Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.}, author={Camac ER and Voelker H and Criner GJ and COPD Clinical Research Network and the Canadian Institutes of Health Research}, journal={Respir Med}, volume={186}, pages={106526}}"}}, {"_id": "37381964", "pmid": 37381964, "title": "[Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance].", "journal": "Zhongguo Zhong Yao Za Zhi", "authors": ["Wu XC", "Liu Y", "Bai ZP"], "date": "2023-06-01T00:00:00Z", "doi": "10.19540/j.cnki.cjcmm.20221014.702", "meta_date_publication": "2023 Jun", "meta_volume": "48", "meta_issue": "11", "meta_pages": "3055-3065", "score": 50246.2, "text_hl": "Ninety rats were randomly divided into a normal group, a model group, low-dose, medium-dose, and high-dose Compound Tinglizi Decoction groups, and a @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group. The rat model of @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD-PH@@@ was established by fumigation combined with @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@lipopolysaccharide@@@(@CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@) intravascular infusion, which lasted 60 days. ", "citations": {"NLM": "Wu XC, Liu Y, Bai ZP. [Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance]. Zhongguo Zhong Yao Za Zhi. 2023 Jun;48(11):3055-3065. PMID: 37381964", "BibTeX": "@article{37381964, title={[Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance].}, author={Wu XC and Liu Y and Bai ZP}, journal={Zhongguo Zhong Yao Za Zhi}, volume={48}, number={11}, pages={3055-3065}}"}}, {"_id": "25184879", "pmid": 25184879, "title": "Simvastatin in moderate-to-severe COPD.", "journal": "N Engl J Med", "authors": ["Egom EE"], "date": "2014-09-04T00:00:00Z", "doi": "10.1056/NEJMc1408400", "meta_date_publication": "2014 Sep 4", "meta_volume": "371", "meta_issue": "10", "meta_pages": "969", "score": 50082.133, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in moderate-to-severe @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@.", "citations": {"NLM": "Egom EE. Simvastatin in moderate-to-severe COPD. N Engl J Med. 2014 Sep 4;371(10):969. PMID: 25184879", "BibTeX": "@article{25184879, title={Simvastatin in moderate-to-severe COPD.}, author={Egom EE}, journal={N Engl J Med}, volume={371}, number={10}, pages={969}}"}}, {"_id": "25184880", "pmid": 25184880, "title": "Simvastatin in moderate-to-severe COPD.", "journal": "N Engl J Med", "authors": ["Suissa S"], "date": "2014-09-04T00:00:00Z", "doi": "10.1056/NEJMc1408400", "meta_date_publication": "2014 Sep 4", "meta_volume": "371", "meta_issue": "10", "meta_pages": "969-70", "score": 50082.133, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in moderate-to-severe @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@.", "citations": {"NLM": "Suissa S. Simvastatin in moderate-to-severe COPD. N Engl J Med. 2014 Sep 4;371(10):969-70. PMID: 25184880", "BibTeX": "@article{25184880, title={Simvastatin in moderate-to-severe COPD.}, author={Suissa S}, journal={N Engl J Med}, volume={371}, number={10}, pages={969-70}}"}}]}